There are good physiologic factors that could account for why HBOT may have valuable outcomes on particular ocular ailments. Corneal edema with many etiologies and anterior phase ischemia, particularly when related with sickle-mobile anemia, appear to be a proper indicator for HBOT. Integrated kn